BRIEF published on 05/05/2025 at 09:10, 1 year 1 month ago BioNxt Solutions Secures Patent Acceptance from Eurasian Patent Organization Innovation Autoimmune Diseases Drug Delivery BioNxt Solutions Eurasian Patent
BRIEF published on 05/05/2025 at 09:10, 1 year 1 month ago BioNxt Solutions obtient l'acceptation de son brevet auprès de l'Organisation eurasienne des brevets Innovation Maladies Auto-immunes Solutions BioNxt Administration De Médicaments Brevet Eurasien
PRESS RELEASE published on 05/05/2025 at 09:05, 1 year 1 month ago BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization BioNxt Solutions Inc. announces acceptance of its first national level patent filing by Eurasian Patent Organization, covering sublingual drug delivery for neurodegenerative diseases BioNxt Solutions Inc. Patent Filing Neurodegenerative Diseases Sublingual Delivery Eurasian Patent Organization
BRIEF published on 05/02/2025 at 01:55, 1 year 1 month ago BioNxt Solutions Delays 2024 Annual Financial Statement Filing Management Cease Trade Order Healthcare Innovation Financial Statements Delay Annual Filings BioNxt Solutions
BRIEF published on 05/02/2025 at 01:55, 1 year 1 month ago BioNxt Solutions retarde le dépôt de ses états financiers annuels pour 2024 Dépôts Annuels Solutions BioNxt Retard Des États Financiers Innovation Dans Le Domaine Des Soins De Santé Ordonnance De Cessation D'opérations De La Direction
PRESS RELEASE published on 05/02/2025 at 01:50, 1 year 1 month ago BioNxt Solutions Announces Delay In Filing 2024 Annual Financial Statements BioNxt Solutions Inc. announces delay in filing annual financial statements for year ended December 31, 2024. Company working on completing filings by June 28, 2025, under management cease trade order Financial Statements Management Cease Trade Order BioNxt Solutions Inc. Delay Regulatory Authorities
BRIEF published on 04/23/2025 at 09:10, 1 year 2 months ago BioNxt Solutions Advances in MS Treatment Study Multiple Sclerosis Cladribine Drug Delivery Innovation BioNxt Solutions Bioequivalence Study
BRIEF published on 04/23/2025 at 09:10, 1 year 2 months ago BioNxt Solutions progresse dans une étude sur le traitement de la sclérose en plaques Sclérose En Plaques Cladribine Solutions BioNxt Étude De Bioéquivalence Innovation En Matière D'administration De Médicaments
PRESS RELEASE published on 04/23/2025 at 09:05, 1 year 2 months ago BioNxt Solutions Prepares for Human Bioequivalence Study For MS BioNxt Solutions Inc. reports advanced preparation for human bioequivalence study of BNT23001, a novel sublingual thin-film Cladribine formulation for Multiple Sclerosis treatment BioNxt Solutions Inc. Multiple Sclerosis Treatment Sublingual Thin-Film BNT23001 Human Bioequivalence Study
BRIEF published on 03/15/2025 at 00:05, 1 year 3 months ago BioNxt Solutions Closes Final Tranche of Convertible Debenture Offering Private Placement Convertible Debenture Warrants Financing BioNxt Solutions
Published on 06/24/2026 at 14:45, 1 hour 53 minutes ago Amdocs Selected by Three Scandinavia to Support Customer Engagement Transformation Across Nordic Markets
Published on 06/24/2026 at 14:00, 2 hours 38 minutes ago GameSquare and U.S. Army Partner for Soldier Showdown 8, Presented by USAA
Published on 06/24/2026 at 14:00, 2 hours 38 minutes ago Adcore Announces Voting Results from Annual Shareholders Meeting
Published on 06/24/2026 at 13:05, 3 hours 33 minutes ago Faraday Copper Reports Drill Results Including Near-Surface Copper Mineralization in the American Eagle Area
Published on 06/24/2026 at 13:00, 3 hours 38 minutes ago Aston Bay Provides Update on the Storm Copper Project - Advancing Towards Development
Published on 06/24/2026 at 16:05, 32 minutes ago Tencent Backs Next-Gen Decarbonization Innovators with Catalytic Funding Through CarbonX 2.0 and Advances Progress Towards Climate Goals
Published on 06/24/2026 at 16:05, 32 minutes ago Sunwoda Energy Launches SunESS H Series and Deepens European Partnerships
Published on 06/24/2026 at 16:00, 38 minutes ago Dynamics Group accueille Mark Seall comme nouvel associé - Cette nomination vient renforcer les compétences technologiques du groupe de conseil dans un environnement marqué par l’IA
Published on 06/24/2026 at 15:49, 48 minutes ago Edison issues report on SDCL Efficiency Income Trust (SEIT)
Published on 06/24/2026 at 15:44, 54 minutes ago Eckert & Ziegler SE Annual General Meeting Approves Significantly Higher Dividend
Published on 06/24/2026 at 16:21, 16 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of May 31, 2026
Published on 06/24/2026 at 16:21, 16 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 mai 2026
Published on 06/24/2026 at 16:17, 20 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of April 30, 2026
Published on 06/24/2026 at 16:17, 20 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 30 avril 2026
Published on 06/24/2026 at 09:30, 7 hours 8 minutes ago CP HOPENING - Le 1er Baromètre “Libéralités - Grande Transmission”
